{"id":"https://openalex.org/W1541923280","doi":"https://doi.org/10.1111/j.1600-0447.2010.01619.x","title":"Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies","display_name":"Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies","alternate_titles":[],"publication_year":2010,"publication_date":"2010-10-12","ids":{"openalex":"https://openalex.org/W1541923280","doi":"https://doi.org/10.1111/j.1600-0447.2010.01619.x","mag":"1541923280","pmid":"https://pubmed.ncbi.nlm.nih.gov/20946203"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0447.2010.01619.x","doi":"https://doi.org/10.1111/j.1600-0447.2010.01619.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.2010.01619.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1541923280"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026519715","display_name":"Simon Davies","orcid":"https://orcid.org/0000-0003-0095-5993","observed_orcids":["https://orcid.org/0000-0003-0095-5993"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"S. J. C. Davies","raw_affiliation_strings":["University of Bristol, UK. simon.davies@bristol.ac.uk","Academic Unit of Psychiatry, University of Bristol, Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bristol, UK. simon.davies@bristol.ac.uk","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"Academic Unit of Psychiatry, University of Bristol, Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085342744","display_name":"Andreas Austgulen Westin","orcid":"https://orcid.org/0000-0002-9198-5137","observed_orcids":["https://orcid.org/0000-0002-9198-5137"]},"institutions":[{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. A. Westin","raw_affiliation_strings":["Department of Clinical Pharmacology, St. Olav\u2019s University Hospital, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St. Olav\u2019s University Hospital, Trondheim, Norway","institution_ids":["https://openalex.org/I4210104358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015474937","display_name":"Ingrid Castberg","orcid":"https://orcid.org/0000-0003-1400-6545","observed_orcids":["https://orcid.org/0000-0003-1400-6545"]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]},{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I. Castberg","raw_affiliation_strings":["Department of Clinical Pharmacology, St. Olav\u2019s University Hospital, Trondheim, Norway","Department of Laboratory Medicine, Children\u2019s and Women\u2019s Health, Norwegian University of Science and Technology, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St. Olav\u2019s University Hospital, Trondheim, Norway","institution_ids":["https://openalex.org/I4210104358"]},{"raw_affiliation_string":"Department of Laboratory Medicine, Children\u2019s and Women\u2019s Health, Norwegian University of Science and Technology, Trondheim, Norway","institution_ids":["https://openalex.org/I204778367"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055543220","display_name":"Glyn Lewis","orcid":"https://orcid.org/0000-0001-5205-8245","observed_orcids":["https://orcid.org/0000-0001-5205-8245"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Lewis","raw_affiliation_strings":["Academic Unit of Psychiatry, University of Bristol, Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Unit of Psychiatry, University of Bristol, Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108073747","display_name":"Martin S Lennard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. S. Lennard","raw_affiliation_strings":["Academic Unit of Clinical Pharmacology, University of Sheffield, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Unit of Clinical Pharmacology, University of Sheffield, Sheffield, UK","institution_ids":["https://openalex.org/I91136226"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Taylor","raw_affiliation_strings":["Academic Unit of Clinical Pharmacology, University of Sheffield, Sheffield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Unit of Clinical Pharmacology, University of Sheffield, Sheffield, UK","institution_ids":["https://openalex.org/I91136226"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031025442","display_name":"Olav Spigset","orcid":"https://orcid.org/0000-0001-7902-9014","observed_orcids":["https://orcid.org/0000-0001-7902-9014"]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]},{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"O. Spigset","raw_affiliation_strings":["Department of Clinical Pharmacology, St. Olav\u2019s University Hospital, Trondheim, Norway","Department of Laboratory Medicine, Children\u2019s and Women\u2019s Health, Norwegian University of Science and Technology, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St. Olav\u2019s University Hospital, Trondheim, Norway","institution_ids":["https://openalex.org/I4210104358"]},{"raw_affiliation_string":"Department of Laboratory Medicine, Children\u2019s and Women\u2019s Health, Norwegian University of Science and Technology, Trondheim, Norway","institution_ids":["https://openalex.org/I204778367"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5026519715"],"corresponding_institution_ids":["https://openalex.org/I36234482"],"apc_list":{"value":4880,"currency":"USD","value_usd":4880},"apc_paid":null,"fwci":0.9966,"has_fulltext":false,"cited_by_count":178,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.69817968,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"122","issue":"6","first_page":"444","last_page":"453"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zuclopenthixol","display_name":"zuclopenthixol","score":1.0},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.7789999842643738},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.8730000257492065},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":1.0},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibitors","display_name":"cytochrome P450 inhibitors","score":0.8489999771118164},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7369999885559082},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.8659999966621399},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9350000023841858},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.8970000147819519},{"id":"https://openalex.org/keywords/levomepromazine","display_name":"levomepromazine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ketoconazole","display_name":"ketoconazole","score":0.9319999814033508},{"id":"https://openalex.org/keywords/quinidine","display_name":"quinidine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/antipsychotic-pharmacokinetics","display_name":"antipsychotic pharmacokinetics","score":0.7789999842643738}],"concepts":[{"id":"https://openalex.org/C2780656706","wikidata":"https://www.wikidata.org/wiki/Q417204","display_name":"Levomepromazine","level":4,"score":0.7014201283454895},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.7006000280380249},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6731640100479126},{"id":"https://openalex.org/C2781064554","wikidata":"https://www.wikidata.org/wiki/Q407883","display_name":"Ketoconazole","level":3,"score":0.6103302836418152},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.5947351455688477},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.5733751654624939},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5646476149559021},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.523490309715271},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.499603271484375},{"id":"https://openalex.org/C2780339425","wikidata":"https://www.wikidata.org/wiki/Q412496","display_name":"Quinidine","level":2,"score":0.44428950548171997},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.44353240728378296},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4146333336830139},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.3610314130783081},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33423709869384766},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.19915416836738586},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.15425452589988708},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.08369055390357971},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.0},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003006","descriptor_name":"Clopenthixol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003006","descriptor_name":"Clopenthixol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007654","descriptor_name":"Ketoconazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008728","descriptor_name":"Methotrimeprazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011802","descriptor_name":"Quinidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018692","descriptor_name":"Antimanic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1600-0447.2010.01619.x","doi":"https://doi.org/10.1111/j.1600-0447.2010.01619.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.2010.01619.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},{"id":"pmid:20946203","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20946203","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta psychiatrica Scandinavica","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1396914","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1396914/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ACTA PSYCHIATRICA SCANDINAVICA , 122 (6) pp. 444-453. (2010)","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1507718585","https://openalex.org/W1963614578","https://openalex.org/W1973644343","https://openalex.org/W1992257495","https://openalex.org/W1993858402","https://openalex.org/W2000844824","https://openalex.org/W2020944051","https://openalex.org/W2028010713","https://openalex.org/W2029660222","https://openalex.org/W2044976930","https://openalex.org/W2047209698","https://openalex.org/W2058523736","https://openalex.org/W2071332031","https://openalex.org/W2084253209","https://openalex.org/W2126704601","https://openalex.org/W2131614625","https://openalex.org/W2154937949","https://openalex.org/W2327559947","https://openalex.org/W2416351818","https://openalex.org/W2422181003","https://openalex.org/W2493886745","https://openalex.org/W3216674547","https://openalex.org/W4211245027","https://openalex.org/W4229668875","https://openalex.org/W4232486832"],"related_works":["https://openalex.org/W3094947720","https://openalex.org/W1976411805","https://openalex.org/W2318493532","https://openalex.org/W2422181003","https://openalex.org/W2554134408","https://openalex.org/W2769915364","https://openalex.org/W2802830869","https://openalex.org/W6982430086","https://openalex.org/W139215090","https://openalex.org/W2319401507"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Zuclopenthixol":[1],"pharmacokinetics":[2],"is":[3,175],"incompletely":[4],"characterised.":[5],"We":[6],"investigated":[7],"potential":[8,202],"interactions":[9,199],"mediated":[10],"through":[11],"cytochrome":[12],"P450":[13],"enzymes.":[14],"METHOD:":[15],"In":[16,74,170],"vitro,":[17],"we":[18,37],"examined":[19],"the":[20,125,188,201],"impact":[21,189],"of":[22,190],"CYP2D6":[23,179],"and":[24,79,87,106,113,115,137,144,180],"CYP3A4":[25],"inhibitors":[26,192],"on":[27],"zuclopenthixol":[28,41,64,84,91,96,127,159,174],"metabolism":[29],"in":[30,43,124],"microsomes":[31],"from":[32,46,52],"six":[33],"human":[34],"livers.":[35],"Subsequently,":[36],"compared":[38],"dose-corrected":[39,94],"serum":[40,97,151],"concentrations":[42,98],"923":[44],"samples":[45],"a":[47],"therapeutic":[48],"drug":[49],"monitoring":[50],"database":[51],"patients":[53],"prescribed":[54],"oral":[55,95,126],"(n":[56,61],"=":[57,62,140],"490)":[58],"or":[59,66,71,193,206],"injected":[60,158],"423)":[63],"alone":[65],"with":[67,110,118],"fluoxetine,":[68,76,111],"paroxetine,":[69,77],"levomepromazine":[70,114,145],"carbamazepine.":[72,119],"RESULTS:":[73],"vitro":[75,171],"ketoconazole":[78],"quinidine":[80,88],"all":[81,164],"significantly":[82],"inhibited":[83],"metabolism.":[85],"Ketoconazole":[86],"together":[89],"abolished":[90],"disappearance.":[92],"Clinically,":[93],"increased":[99],"significantly,":[100],"after":[101],"adjustment,":[102],"by":[103,178],"93%,":[104],"78%":[105],"46%":[107],"during":[108],"co-treatment":[109],"paroxetine":[112,138],"decreased":[116],"67%":[117],"Carbamazepine":[120],"caused":[121],"dose-dependent":[122,142],"reductions":[123],"concentration-dose":[128],"ratio":[129],"(P":[130,134,139,153],"<":[131,135,154],"0.001),":[132],"fluoxetine":[133],"0.001)":[136],"0.011)":[141],"increases":[143],"an":[146],"increase":[147],"related":[148],"to":[149],"its":[150],"concentration":[152],"0.001).":[155],"Results":[156],"for":[157,203],"were":[160],"similar":[161],"but":[162],"not":[163],"reached":[165],"statistical":[166],"significance.":[167],"CONCLUSION:":[168],"The":[169,182],"study":[172,184],"suggests":[173],"metabolised":[176],"primarily":[177],"CYP3A4.":[181],"clinical":[183],"supports":[185],"this,":[186],"demonstrating":[187],"co-prescribed":[191],"inducers.":[194],"Guidelines":[195],"should":[196],"incorporate":[197],"these":[198],"noting":[200],"zuclopenthixol-related":[204],"toxicity":[205],"treatment":[207],"failure.":[208]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1541923280","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":159},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
